Pulse Surveys: Q1 2024

Share on facebook
Share on twitter
Share on email
Share on whatsapp
Share on linkedin

Every Sunday, we run a quick poll on the hottest subject in the Tobacco Industry. Hundreds of our Twitter/X followers vote, offering a collective wisdom on the subject matter or an immediate pulse on the market/industry developments.

Results of the Sunday polls:

March 31, 2024

Which tobacco major will deliver the best Total Shareholder Return (price appreciation plus dividends) in the next 12 months?

– BAT: 69%

– PMI: 16%

– Altria: 9%

– Imperial Brands: 6%

Note: Repeating the October 29, 2023 Poll

March 24, 2024

Sunday Poll: Does Philip Morris International (PMI) understate the regulatory, fiscal and social risks surrounding ZYN and IQOS?

– Yes (PMI understates): 55%

– No (PMI provides reasonable, comprehensive and timely risk assessments): 45%

March 17, 2024

Both BAT and Altria sold shares of their main associates (ITC & Anheuser-Busch InBev) to buy back their own shares. Are these smart or ill-conceived moves? In terms of (1) Rationale/need to divest (2) Use of proceeds

– Both smart: 43%

– BAT smart, Altria ill-conceived: 39%

– Both ill-conceived: 12%

– Altria smart, BAT ill-conceived: 5%

March 10, 2024

Which one is the most valuable nicotine brand in the world? (considering a 20-year time horizon)

– Marlboro: 34%

– IQOS: 31%

– Zyn: 21%

– Vuse: 14%

March 3, 2024

How will the recent developments surrounding ZYN in the US play out for PMI?

– Too early to tell: 43%

– No impact: 31%

– Some regulatory & fiscal measures and social backlash leading to lower growth: 18%

– Major legal settlement and/or asset impairment charges for PMI (from growth to decline): 8%

Feburary 25, 2024

Which piece of news from PMI’s CAGNY presentation did you like the most?

– No slow-down in IQOS growth: 48%

– Commitment to deliver growth in US$ terms: 22%

– Nothing: 21%

– Share gains in e-vapor (select markets): 10%

Feburary 18, 2024

Would you support BAT selling its entire ITC stake ($17.6Bn) to acquire Imperial Brands ($20.4Bn)? Swapping a disconnected fast-growth business with a waning cash cow (~$3Bn FCF in FY23) that can be fully integrated (cost savings)

– No: 65%

– Yes: 35%

Feburary 11, 2024

Do you support BAT’s plan to reduce its ITC stake?

– Yes: 57%

– No: 43%

Feburary 4, 2024 – Part III

Re-initiation of the share repurchase program is the most anticipated announcement for BAT’s FY23 Earnings release. Should BAT re-initiate share buybacks or continue to focus on debt reduction?

– Continue to reduce debt: 51%

– Re-initiate share buybacks: 49%

Feburary 4, 2024 – Part II

BAT will release the FY23 results on Feburary 8, 2024. How will the share price react?

– No significant move ($30/£23.5): 45%

– Move above MA200 ($32/£25.5): 31%

– New 52-week low ($28/£22): 24%

Feburary 4, 2024 – Part I

PMI will release the FY23 results on Feburary 8, 2024. Shares are stuck in $88-$100 range since the Q1 2023 release (April 2023). How will the share price react?

– No significant move: 65%

– New 52-week low (<$88): 19%

– Move above $100: 16%

January 28, 2024

Altria will release its Q4 2023 results on Feburary 1, 2024 (Thursday). How will the stock react?

– Next Leg Down: 43%

– No significant move: 42%

– Relief Rally: 15%

January 21, 2024

What will be the US cigarette market share of IQOS in 2032 (i.e. five years after nationwide expansion)?

– Less than 5%: 21%

– 5%-10%: 28%

– 10%-20%: 28%

– More than 20%: 23%

January 14, 2024

Which e-cigarette flavors should Regulators permit?

– All flavors (including sweet & fruity): 75%

– Only Menthol & Tobacco: 11%

– All non-sweet/fruity flavors (coffee, clove, star anise, etc. in addition to menthol & tobacco): 7%

– Only Tobacco: 7%

January 7, 2024

What will be the most important event for the Tobacco Industry in 2024?

– E-cigarette clampdown (US & elsewhere): 32%

– Menthol ban in the US: 28%

– IQOS launch in the US: 28%

– An unpredictable event (that will turn out to be more important than the events listed above): 12%

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address